(Q47993951)

7 February 2018

title

Minor components of a multi-envelope HIV vaccine are recognized by type-specific T-helper cells (English)

1 reference

7 February 2018

1

Xiaoyan Zhan

1 reference

7 February 2018

Julia L. Hurwitz

6

object named as

Julia L Hurwitz

1 reference

7 February 2018

Sherri L Surman

3

object named as

Sherri Surman

1 reference

7 February 2018

Karen Slobod

2

object named as

Karen S Slobod

1 reference

7 February 2018

author name string

Scott A Brown

4

1 reference

7 February 2018

Chris Coleclough

5

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 March 2004

1 reference

7 February 2018

published in

Vaccine

1 reference

7 February 2018

volume

22

1 reference

7 February 2018

issue

9-10

1 reference

7 February 2018

page(s)

1206-1213

1 reference

7 February 2018

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.028

Immune responses to SIVmne envelope glycoproteins protect macaques from homologous SIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.028

Genetic and immunologic characterization of viruses infecting MN-rgp120-vaccinated volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.028

Progress in HIV vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.028

Multi-envelope HIV vaccine safety and immunogenicity in small animals and chimpanzees.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.028

Eliciting HIV-1 envelope-specific antibodies with mixed vaccinia virus recombinants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.028

Disquisitions of Original Antigenic Sin. I. Evidence in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.028

Sequential immunizations with rgp120s from independent isolates of human immunodeficiency virus type 1 induce the preferential expansion of broadly crossreactive B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.028

Localization of CD4+ T cell epitope hotspots to exposed strands of HIV envelope glycoprotein suggests structural influences on antigen processing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.028

LacZ inducible, antigen/MHC-specific T cell hybrids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.028

Requirement for cotolerogenic gene products in the clonal deletion of I-E reactive T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.028

A highly sensitive single-cell assay detects T-helper cell responses missed by conventional interleukin-2-based methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.028

A five-residue HIV envelope helper T cell determinant: does this peptide-MHC interaction leave the binding groove half empty?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.028

Screening of HIV-1 Env glycoproteins for the ability to raise neutralizing antibody using DNA immunization and recombinant vaccinia virus boosting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.028

Protection against mycoplasma infection using expression-library immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.028

Biological features of genetic immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.028

Cytotoxic T cell polyepitope vaccines delivered by ISCOMs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.028

Construction of peptides encompassing multideterminant clusters of human immunodeficiency virus envelope to induce in vitro T cell responses in mice and humans of multiple MHC types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.028

Anchor sequence-dependent endogenous processing of human immunodeficiency virus 1 envelope glycoprotein gp160 for CD4+ T cell recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.028

10.1016/J.VACCINE.2003.09.028

7 January 2021

Identifiers

DOI

1 reference

7 February 2018

release_vyp7yh4hvna2pdwnkocyennmhm

Fatcat ID

0 references

1 reference

7 February 2018